Atherosclerosis is an inflammatory disorder after all

Area of Science:

• Cardiovascular Science
• Immunology
• Pharmacology

Background:

• Atherosclerosis was traditionally viewed as a cholesterol disorder.
• Emerging evidence highlights inflammation as a key driver in atherosclerosis pathogenesis.
• Cholesterol contributes to atherosclerosis via inflammatory pathways.

Purpose of the Study:

• To elucidate the role of inflammation in atherosclerosis.
• To discuss the anti-inflammatory effects of statins in cardiovascular disease.
• To explore novel therapeutic targets for atherosclerosis.

Main Methods:

• Review of current scientific literature on atherosclerosis and inflammation.
• Analysis of the mechanisms by which cholesterol impacts vascular inflammation.
• Evaluation of statin's cholesterol-dependent and independent anti-inflammatory actions.

Main Results:

• Atherosclerosis is fundamentally an inflammatory condition.
• Statins effectively reduce vascular inflammation, thereby preventing heart disease.
• Statins possess anti-inflammatory properties beyond cholesterol reduction.

Conclusions:

• Inflammation is central to atherosclerosis pathophysiology.
• Targeting inflammatory mechanisms offers a promising therapeutic strategy for atherosclerosis.
• Statins represent a crucial therapeutic intervention for managing atherosclerosis through combined lipid-lowering and anti-inflammatory effects.